Symbiotic Capital

Symbiotic Capital is a lending firm based in Los Angeles, California, established in 2022. The company specializes in providing credit solutions within the life sciences sector, focusing on supporting businesses in this industry through tailored financial products. By leveraging its expertise in life sciences, Symbiotic Capital aims to facilitate growth and innovation among its clients.

Josh Bradley

SMD and Co-Founder

3 past transactions

Alira Health

Debt Financing in 2024
Alira Health is an international advisory firm that specializes in providing integrated transaction advisory, management consulting, medical affairs advisory, and innovative research services for healthcare and life science companies. Founded in 1999 and headquartered in the United States, Alira Health collaborates with strategists, bankers, doctors, and scientists to deliver comprehensive insights across various facets of healthcare. The firm assists multinational corporations, institutional investors, creditors, and governments in activities such as company sales, acquisitions, strategic partnerships, and financial restructurings, aiming to enhance the efficiency and effectiveness of funding and operational strategies worldwide.

Caresyntax

Series C in 2024
Caresyntax Inc. is a Boston-based company that provides a digital surgery platform to enhance surgical performance in hospitals and ambulatory surgical centers. Founded in 1991, it leverages data from over 1,600 hospitals globally to deliver insights that improve patient outcomes and operational efficiency. The platform integrates various data sources, including video, audio, clinical, and operational data, enabling real-time analysis and decision-making during surgeries. Caresyntax offers solutions such as qvident, a performance management software, and PRIME365, a comprehensive integration platform that consolidates surgical data and content. With a focus on automating workflows and reducing surgical variability, Caresyntax supports over 4,000 operating rooms and has facilitated millions of surgical procedures worldwide. The company’s HIPAA-compliant software can be deployed on-premise, in the cloud, or in a hybrid format, making it adaptable to diverse healthcare environments.

Accelus

Debt Financing in 2024
Accelus specializes in developing medical implants aimed at enhancing minimally invasive spine surgery. The company focuses on expandable interbody technology, offering a bi-directional expandable cage that combines the strength and rigidity of a traditional monolithic implant. This innovative design allows healthcare professionals to effectively address various spinal issues, including height, weight, and lordosis problems. Accelus is dedicated to improving access to its advanced surgical solutions, particularly in markets that have been historically underserved.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.